2- year Warranty. Lifetime Customer Support, 10-Year Parts Availability Rightway Collection of optomtery equipment for modern eye care practices-auto refractomner, slit lamps, lensmeter, and vision testing instrument i
Currency:
USD
USD EUR GBP JPY AED AUD BRL CAD CHF DKK HKD IDR INR KRW MOP MYR NOK NZD PHP RUB SAR SEK THB TRY TWD SGD ZAR
Language:
English
English Deutsch Français Русский にほんご 한국어 Español Português Italiano العربية Nederlands Ελληνικά
Sign In or Join Free
English
English
Deutsch
Français
Русский
にほんご
한국어
Español
Português
Italiano
العربية
Nederlands
Ελληνικά
USD
USD
EUR
GBP
JPY
AED
AUD
BRL
CAD
CHF
DKK
HKD
IDR
INR
KRW
MOP
MYR
NOK
NZD
PHP
RUB
SAR
SEK
THB
TRY
TWD
SGD
ZAR
Search History
You May Also Like
Stable phoropter mount supplier, Smooth rotation phoropter arm, Custom ophthalmic mount OEM Eyeglass lens testing machine、Portable auto lensmeter, Touch screen lensometer, Compact focimeter for clinic Electric optometry patient chair for sale,Height adjustable eye clinic chair manufacturer,Hospital ophthalmic patient chair CE certified edging machine, 3-point centering lens edger, Automatic lens blocker edger Clinic PD measurement device, Optical shop pupillometer, CE certified PD meter High precision eye refractometer supplier, Custom optometry instrument OEM, Portable auto refractometer Ophthalmoscope, Direct Ophthalmoscope, Indirect Ophthalmoscope Optometry Trial Lenses, Ophthalmic Trial Lens Set, Eye Testing Trial Lenses Clinic eye testing projector, Optical shop visual acuity device, CE certified chart projector, LED light source projector, Wall mounted vision tester
Home / Blogs /
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Home Blogs
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

November 02, 2019

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focused on the discovery, development, and commercialization of therapeutics for vascular diseases. It was founded in July 2012 and is led by President and CEO, Dr. George Nikopoulos. Q BioMed and Mannin have been partners since 2015.

WhatsApp